Daehan Nupharm

대한뉴팜 · 054670

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$59.2M (₩81.7B)

Overview

Daehan Nupharm is a South Korean pharmaceutical company that develops and supplies finished medicines, prescription and over-the-counter drugs used by patients and healthcare providers.

It is listed on KOSDAQ, Korea's technology and small-cap stock exchange. The filing's table of contents covers product lines, raw materials and production facilities, sales activity, and active research and development programs, indicating a broad pharmaceutical operation spanning manufacturing inputs through to commercialized products.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$146.7M

▲ +0.1% YoY

Operating profit · FY2025

US$8.5M

▼ −37.2% YoY

Net income · FY2025

US$11.1M

▼ −1.4% YoY

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$148M(₩204.2B)	US$146.5M(₩202.2B)	US$146.7M(₩202.4B)
Operating profit	US$13.6M(₩18.8B)	US$13.5M(₩18.7B)	US$8.5M(₩11.7B)
Net income	US$9.1M(₩12.5B)	US$11.2M(₩15.5B)	US$11.1M(₩15.3B)

Revenue

FY2023US$148M
FY2024US$146.5M
FY2025US$146.7M

Operating profit

FY2023US$13.6M
FY2024US$13.5M
FY2025US$8.5M

Net income

FY2023US$9.1M
FY2024US$11.2M
FY2025US$11.1M

Key ratios (FY2025)

ROE

10.9%

Debt/Eq

93.8%

Op. margin

5.8%

Net margin

7.5%

Rev. YoY

▲ +0.1%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?